Rawat M, Padalino G, Adika E, Okombo J, Yeo T, Brancale A
PLoS Pathog. 2025; 21(2):e1012216.
PMID: 39899599
PMC: 11809919.
DOI: 10.1371/journal.ppat.1012216.
Kore M, Acharya D, Sharma L, Vembar S, Sundriyal S
BMC Chem. 2025; 19(1):28.
PMID: 39885590
PMC: 11783816.
DOI: 10.1186/s13065-025-01395-4.
Oyeneyin O, Moodley R, Mashaba C, Garnie L, Omoboyowa D, Rakodi G
Heliyon. 2024; 10(19):e38434.
PMID: 39397937
PMC: 11471183.
DOI: 10.1016/j.heliyon.2024.e38434.
Kanai M, Mok S, Yeo T, Shears M, Ross L, Jeon J
bioRxiv. 2024; .
PMID: 39386571
PMC: 11463348.
DOI: 10.1101/2024.09.27.615529.
Amod L, Mohunlal R, Teixeira N, Egan T, Wicht K
Sci Rep. 2023; 13(1):2648.
PMID: 36788274
PMC: 9929333.
DOI: 10.1038/s41598-023-29273-w.
Adsorption to the Surface of Hemozoin Crystals: Structure-Based Design and Synthesis of Amino-Phenoxazine β-Hematin Inhibitors.
Olivier T, Loots L, Kok M, de Villiers M, Reader J, Birkholtz L
ChemMedChem. 2022; 17(10):e202200139.
PMID: 35385211
PMC: 9119941.
DOI: 10.1002/cmdc.202200139.
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance.
Murithi J, Deni I, Pasaje C, Okombo J, Bridgford J, Gnadig N
Cell Chem Biol. 2021; 29(5):824-839.e6.
PMID: 34233174
PMC: 8727639.
DOI: 10.1016/j.chembiol.2021.06.006.
Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.
de Villiers K, Egan T
Acc Chem Res. 2021; 54(11):2649-2659.
PMID: 33982570
PMC: 8290263.
DOI: 10.1021/acs.accounts.1c00154.
Insights into structural and physicochemical properties required for β-hematin inhibition of privileged triarylimidazoles.
Veale C, Jayram J, Naidoo S, Laming D, Swart T, Olivier T
RSC Med Chem. 2021; 11(1):85-91.
PMID: 33479606
PMC: 7522795.
DOI: 10.1039/c9md00468h.
Overcoming cancer therapeutic bottleneck by drug repurposing.
Zhang Z, Zhou L, Xie N, Nice E, Zhang T, Cui Y
Signal Transduct Target Ther. 2020; 5(1):113.
PMID: 32616710
PMC: 7331117.
DOI: 10.1038/s41392-020-00213-8.
Naphthylisoquinoline alkaloids, validated as hit multistage antiplasmodial natural products.
Moyo P, Shamburger W, van der Watt M, Reader J, De Sousa A, Egan T
Int J Parasitol Drugs Drug Resist. 2020; 13:51-58.
PMID: 32505117
PMC: 7270141.
DOI: 10.1016/j.ijpddr.2020.05.003.
Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
De Sousa A, Maepa K, Combrinck J, Egan T
Molecules. 2020; 25(7).
PMID: 32235391
PMC: 7180468.
DOI: 10.3390/molecules25071571.
Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.
Labbate F, Muller R, Openshaw R, Combrinck J, de Villiers K, Hunter R
Eur J Med Chem. 2018; 159:243-254.
PMID: 30296683
PMC: 6232849.
DOI: 10.1016/j.ejmech.2018.09.060.
The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization.
Fitzroy S, Gildenhuys J, Olivier T, Tshililo N, Kuter D, de Villiers K
Langmuir. 2017; 33(30):7529-7537.
PMID: 28689414
PMC: 5709178.
DOI: 10.1021/acs.langmuir.7b01132.
Identification and Mechanistic Evaluation of Hemozoin-Inhibiting Triarylimidazoles Active against .
Wicht K, Combrinck J, Smith P, Hunter R, Egan T
ACS Med Chem Lett. 2017; 8(2):201-205.
PMID: 28197312
PMC: 5304302.
DOI: 10.1021/acsmedchemlett.6b00416.
High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties.
Huy N, Chi P, Nagai J, Dang T, Mbanefo E, Ahmed A
Antimicrob Agents Chemother. 2016; 61(2).
PMID: 27919903
PMC: 5278743.
DOI: 10.1128/AAC.01607-16.
Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.
Wicht K, Combrinck J, Smith P, Hunter R, Egan T
J Med Chem. 2016; 59(13):6512-30.
PMID: 27299916
PMC: 4945415.
DOI: 10.1021/acs.jmedchem.6b00719.
Detergent-Mediated Formation of β-Hematin: Heme Crystallization Promoted by Detergents Implicates Nanostructure Formation for Use as a Biological Mimic.
Sandlin R, Fong K, Stiebler R, Gulka C, Nesbitt J, Oliveira M
Cryst Growth Des. 2016; 16(5):2542-2551.
PMID: 27175104
PMC: 4860678.
DOI: 10.1021/acs.cgd.5b01580.
Characterization and optimization of the haemozoin-like crystal (HLC) assay to determine Hz inhibiting effects of anti-malarial compounds.
Tempera C, Franco R, Caro C, Andre V, Eaton P, Burke P
Malar J. 2015; 14:403.
PMID: 26458401
PMC: 4603294.
DOI: 10.1186/s12936-015-0913-y.
Identification of β-hematin inhibitors in the MMV Malaria Box.
Fong K, Sandlin R, Wright D
Int J Parasitol Drugs Drug Resist. 2015; 5(3):84-91.
PMID: 26150923
PMC: 4486462.
DOI: 10.1016/j.ijpddr.2015.05.003.